Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
European Journal of Nuclear Medicine and Molecular Imaging
Literature
1.
Thie JA. Understanding the standardized uptake value, its methods, and implications for usage. J Nucl Med. 2004;45:1431–4.PubMed
2.
Carlier T, Bailly C. State-Of-The-Art and Recent Advances in Quantification for Therapeutic Follow-Up in Oncology Using PET. Front Med. 2015;2:18.CrossRef
3.
Lim I, Lindenberg ML, Mena E, Verdini N, Shih JH, Mayfield C, et al. 18F-Sodium fluoride PET/CT predicts overall survival in patients with advanced genitourinary malignancies treated with cabozantinib and nivolumab with or without ipilimumab. Eur J Nucl Med Mol Imaging. 2020;47:178–84.CrossRef
4.
Schmuck S, von Klot CA, Henkenberens C, Sohns JM, Christiansen H, Wester H-J, et al. Initial experience with volumetric Ga-PSMA I&T PET/CT for assessment of whole-body tumor burden as a quantitative imaging biomarker in patients with prostate cancer. J Nucl Med. 2017;58:1962–8.CrossRef
5.
van Velden FH, van Beers P, Nuyts J, Velasquez LM, Hayes W, Lammertsma AA, et al. Effects of rigid and non-rigid image registration on test-retest variability of quantitative [18F]FDG PET/CT studies. EJNMMI Res. 2012;2:10.CrossRef
6.
Benz MR, Allen-Auerbach MS, Eilber FC, Chen HJJ, Dry S, Phelps ME, et al. Combined assessment of metabolic and volumetric changes for assessment of tumor response in patients with soft-tissue sarcomas. J Nucl Med. 2008;49:1579–84.CrossRef
7.
Akhurst T. Tumor burden assessment with positron emission tomography with [18-F] 2-fluoro 2-deoxyglucose (FDG PET) modeled in metastatic renal cell cancer. Clin Positron Imaging. 2000;3:57–65.CrossRef
8.
Reynolds JC, Maass-Moreno R, Thomas A, Ling A, Padiernos EB, Steinberg SM, et al. F-FDG PET Assessment of malignant pleural mesothelioma: total lesion volume and total lesion glycolysis-the central role of volume. J Nucl Med. 2020;61:1570–5.CrossRef
9.
Armstrong IS, Kelly MD, Williams HA, Matthews JC. Impact of point spread function modelling and time of flight on FDG uptake measurements in lung lesions using alternative filtering strategies. EJNMMI Phys. 2014;1:99.CrossRef
10.
Huellner MW, Collen TD, Gut P, Winterhalder R, Pauli C, Diebold J, et al. Multiparametric PET/CT-perfusion does not add significant additional information for initial staging in lung cancer compared with standard PET/CT. EJNMMI Res. 2014;4:6.CrossRef
11.
Nakamoto R, Zaba LC, Rosenberg J, Reddy SA, Nobashi TW, Davidzon G, et al. Prognostic value of volumetric PET parameters at early response evaluation in melanoma patients treated with immunotherapy. Eur J Nucl Med Mol Imaging. 2020;47:2787–95.CrossRef
12.
Qin C, Shao F, Hu F, Song W, Song Y, Guo J, et al. 18F-FDG PET/CT in diagnostic and prognostic evaluation of patients with cardiac masses: a retrospective study. Eur J Nucl Med Mol Imaging. 2020;47:1083–93.CrossRef
13.
Schmidkonz C, Metzler M, Krumbholz M, Kuwert T, Uder M, Bäuerle T. Assessment of treatment responses in children and adolescents with Ewing sarcoma with metabolic tumor parameters derived from 18F-FDG-PET/CT and circulating tumor DNA. Eur J Nucl Med Mol Imaging. 2020;47:1564–75.CrossRef
Metadata
Title
Letter to the Editor: It is time for the nuclear medicine community to define a unit for the total lesion glycolysis (TLG) and similar metrics
Authors
Paulo Schiavom Duarte
Marcelo Tatit Sapienza
Publication date
01-07-2021
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Nuclear Medicine and Molecular Imaging / Issue 8/2021
Print ISSN: 1619-7070
Electronic ISSN: 1619-7089
DOI
https://doi.org/10.1007/s00259-021-05190-w

Other articles of this Issue 8/2021

European Journal of Nuclear Medicine and Molecular Imaging 8/2021 Go to the issue

Letter to the Editor

Spleen glucose metabolism on [18F]-FDG PET/CT: a dynamic double-edged biomarker predicting outcome in cancer patients

Editorial

Multi-scale imaging as an essential tool for precision medicine

Letter to the Editor

Authors’ reply: PSMA-PET: is the time to say goodbye to metabolic radiopharmaceuticals in prostate cancer?

Image of the Month

Complete remission of follicular lymphoma after SARS-CoV-2 infection: from the “flare phenomenon” to the “abscopal effect”

Original Article

Inflammatory response in lungs and extrapulmonary sites detected by [18F] fluorodeoxyglucose PET/CT in convalescing COVID-19 patients tested negative for coronavirus

Editorial

Challenges and future options for the production of lutetium-177